Detalhe da pesquisa
1.
Pasireotide effects on biochemical control and glycometabolic profile in acromegaly patients switched from combination therapies or unconventional dosages of somatostatin analogs.
J Endocrinol Invest
; 47(3): 683-697, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37695461